Clinical Impact of Additional Cytogenetic Aberrations, <i>cKIT</i> and <i>RAS</i> Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group

Kim Klein, Brenda Gibson, Susana C. Raimondi et al.|Journal of Clinical Oncology|2015

Cited by 92